Novavax
NVAX
#5098
Rank
A$2.30 B
Marketcap
A$14.19
Share price
1.09%
Change (1 day)
15.85%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): A$0.60 Billion

According to Novavax's latest financial reports the company's current earnings are A$1.02 Billion. In 2024 the company made an earning of -A$0.23 Billion, an increase over its 2023 earnings that were of -A$0.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.60 B-374.02%
2024 -A$0.23 Billion-70.39%
2023 -A$0.76 Billion-16.59%
2022 -A$0.9 Billion-62.58%
2021 -A$2.41 Billion320.54%
2020 -A$0.58 Billion234.22%
2019 -A$0.18 Billion-30.17%
2018 -A$0.25 Billion1.69%
2017 -A$0.25 Billion-36.44%
2016 -A$0.38 Billion70.4%
2015 -A$0.23 Billion89.27%
2014 -A$0.12 Billion59.83%
2013 -A$73.52 Million81.9%
2012 -A$40.42 Million50.33%
2011 -A$26.89 Million
2009 -A$53.06 Million8.8%
2008 -A$48.77 Million18.01%
2007 -A$41.33 Million18.33%
2006 -A$34.93 Million168.31%
2005 -A$13.02 Million-62.51%
2004 -A$34.73 Million52.4%
2003 -A$22.79 Million-28.21%
2002 -A$31.74 Million
2000 -A$18.09 Million177%
1999 -A$6.53 Million-11.54%
1998 -A$7.39 Million10.64%
1997 -A$6.68 Million-9.62%
1996 -A$7.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$23.20 B 4,260.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$16.82 B 3,060.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$18.57 B 3,390.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$13.23 B 2,386.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-A$0.36 Billion-167.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.37 Billion-168.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$29.32 M-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-A$11.54 Million-102.17%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-A$9.4 Million-101.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-55.92%๐Ÿ‡บ๐Ÿ‡ธ USA